IFNL2 and Huntington disease: As detailed in the methods, here we compare1 IFNα and IFNλ2 serum concentrations2, distribution of immune cell subsets, and3 the frequency of cell markers associated with immune dysfunction in ECs and in untreated and treated non-EC patients, with HD samples as a control.